Second Chances to Improve ESRD Outcomes With a Second-Generation Calcimimetic
JAMA
.
2017 Jan 10;317(2):139-141.
doi: 10.1001/jama.2016.18631.
Authors
John P Middleton
1
,
Myles Wolf
1
Affiliation
1
Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
PMID:
28097342
PMCID:
PMC5507610
DOI:
10.1001/jama.2016.18631
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Hyperparathyroidism, Secondary*
Kidney Failure, Chronic*
Grants and funding
U01 DK099930/DK/NIDDK NIH HHS/United States
R01 DK076116/DK/NIDDK NIH HHS/United States
R01 DK081374/DK/NIDDK NIH HHS/United States
K24 DK093723/DK/NIDDK NIH HHS/United States
R01 DK094796/DK/NIDDK NIH HHS/United States